Phase 2b trial: Prefusion F protein–based respiratory syncytial virus immunization in pregnancy.

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: RSV Prefusion F Protein-Based Immunization Studied in Pregnancy – HealthDay

Commentary on Twitter

In pregnant women, RSVpreF vaccine elicited neutralizing antibody responses with efficient transplacental transfer and without evident safety concerns. https://t.co/r8oktZmBZQ pic.twitter.com/UE7ffxYJW6

— NEJM (@NEJM) April 27, 2022